ArticleWorld journal of urology2025
Surgeon-led vs. nurse-led postoperative follow-up after dilep: impact on erectile function recovery and patient-reported outcomes.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Surgeon-led vs. nurse-led postoperative follow-up after DiLEP: impact on erectile function recovery and patient-reported outcomes".World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWhile 1470 nm Diode Laser Enucleation of the Prostate (DiLEP) effectively treats sexually active patients of benign prostatic hyperplasia, postoperative erectile function preservation remains a concern. This study compares the impact of surgeon-led (SLP) versus nurse-led (NLP) follow-up on erectile function recovery and patient-reported outcomes after DiLEP.
methodsIn this propensity score-matched retrospective cohort study, we analyzed 126 patients undergoing DiLEP (2019-2023), equally divided into SLP and NLP groups. Primary outcomes included International Index of Erectile Function (IIEF) scores and patient-reported outcome measures (PROMs) at 3- and 6-month follow-ups. Secondary outcomes encompassed Lower urinary tract symptoms (LUTS), assessed using the International Prostate Symptom Score (IPSS), treatment satisfaction, evaluated via the Treatment Satisfaction Questionnaire (TS-Q) and psychological distress, measured by the Hospital Anxiety and Depression Scale (HADS).
resultsThe SLP group demonstrated superior erectile function recovery (6-month IIEF: 19.2 ± 2.96 vs. 17.7 ± 2.47, p = 0.003) and higher satisfaction rates (55.6% vs. 28.6%, p = 0.002). PROMs favored SLP at all timepoints (p < 0.05). Notably, SLP patients received earlier PDE5 inhibitor interventions (38.1% vs. 19.1%, p = 0.018), while both groups showed comparable IPSS improvement (p = 0.34). Anxiety scores (HADS-A) were lower in SLP patients (4.2 ± 1.8 vs. 5.1 ± 2.1, p = 0.03).
conclusionSurgeon-led follow-up significantly enhances erectile function recovery and patient satisfaction after DiLEP, potentially through earlier therapeutic interventions. These findings support integrating surgeon expertise into postoperative care pathways, particularly for sexually active patients prioritizing functional recovery.
Indexed as
Identifiers
40652063What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.